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Abstract
BACKGROUND: Articular cartilage lesions occur frequently but unfortunately damaged cartilage has a very limited
intrinsic repair capacity. Therefore, there is a high need to develop technology that makes cartilage repair possible. Since
joint damage will lead to (sterile) inflammation, development of this technology has to take into account the effects of
inflammation on cartilage repair.
METHODS: A literature search has been performed including combinations of the following keywords; cartilage repair,
fracture repair, chondrogenesis, (sterile) inflammation, inflammatory factors, macrophage, innate immunity, and a number
of individual cytokines. Papers were selected that described how inflammation or inflammatory factors affect chondro-
genesis and tissue repair. A narrative review is written based on these papers focusing on the role of inflammation in
cartilage repair and what we can learn from findings in other organs, especially fracture repair.
RESULTS: The relationship between inflammation and tissue repair is not straightforward. Acute, local inflammation
stimulates fracture repair but appears to be deleterious for chondrogenesis and cartilage repair. Systemic inflammation has
a negative effect on all sorts of tissue repair.
CONCLUSION: Findings on the role of inflammation in fracture repair and cartilage repair are not in line. The currently
widely used models of chondrogenesis, using high differentiation factor concentrations and corticosteroid levels, are not
optimal. To make it possible to draw more valid conclusions about the role of inflammation and inflammatory factors on
cartilage repair, model systems must be developed that better mimic the real conditions in a joint with damaged cartilage.
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1 Introduction
Repair of an injured organ occurs when the damaged tissue
is removed, lesions are healed, and inflammation is
resolved. Regeneration, on the other hand, is defined as the
reconstitution of the damaged tissue in a scar-free manner
regaining all the initial functions of the tissue or organ. The
distinction between what drives either repair or regenera-
tion is nowadays an important subject of research to elu-
cidate what signaling networks drive the healing process to
either regeneration or (imperfect) repair. An important
research question is if we can adjust these signaling net-
works for our own good to stimulate more efficient repair
or even regeneration of tissues and organs in humans? A
central element of the healing process is the concomitant
inflammatory response that is an inevitable consequence of
all tissue damage.
Inflammation has in general a bad reputation and is
regarded as a process to avoid or inhibit. However, in the
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context of evolution it is very improbable that nature ‘‘in-
vented’’ such a sophisticated and well-developed system to
damage the individual in which it is occurring. Inflamma-
tion is both an important host defense mechanism and as
well as a trigger to repair damaged tissues. However, there
is a general perception that if inflammation does not
resolve, neither efficient repair nor regeneration will occur
leading to sustained functional problems.
In this review the interplay between repair and inflam-
mation is discussed in the context of tissue damage without
infection (sterile inflammation) focusing on the repair of
cartilage defects. Most studies on the relationship between
tissue healing and inflammation investigate the healing of
soft tissue wounds. However, soft tissue wounds or carti-
lage lesions are very different in their cellular composition,
matrix components and repair response. Although dissim-
ilar from cartilage healing, bone fracture healing can be
expected to have overlapping attributes with cartilage
repair, at least partly with healing of full thickness defects,
since chondrogenesis and cartilage formation is a crucial
aspect of both fracture repair and repair of cartilage full
thickness defects. Therefore, in this narrative review, the
relationship between inflammation and repair will be dis-
cussed in short in a general setting and more specific in
fracture repair. Furthermore, this review discusses what is
known about the role of inflammation and inflammatory
factors in repair of cartilage lesions, including effects of
inflammation on chondrogenesis.
2 Damage and inflammation
Inflammation and repair are not separate entities but a
continuum with common actors that have differential roles
at different stages of the biological response initiated by
tissue damage. Sterile inflammation, as a result of acute or
chronic tissue damage, results in the release of damage-
associated molecular patterns (DAMPS) that initiate the
inflammatory response to injury. DAMPS are endogenous
molecules that indicate tissue damage and are actively or
passively released from injured cells and extracellular
matrix [1]. These DAMPS activate resident cells triggering
these cells to release chemotactic factors that attract
inflammatory cells to the wound site [2, 3]. Activation of
Toll-Like Receptors (TLRs) on cells leads to chemokine
release and attraction of inflammatory cells. Since DAMPS
also induce chemokine release by the cells that enter the
wound site this results in a positive feedback loop that only
ends when the amount of activating DAMPS is ebbed [3].
The cells invading the wound site do not only play an
important role in the initiation of the inflammatory
response but also in the resolution of inflammation.
The first inflammatory cells that are attracted to the site
of damage are neutrophils. Neutrophils are attracted to the
wound site by a chemotactic gradient of molecules released
by damaged tissues and activated cells and platelets. In
zebra fish, reactive oxygen species (ROS) and Interleukin-8
have been shown to be involved in the attraction of neu-
trophils to the wound site [4]. Inhibition of ROS production
impaired the initial recruitment of neutrophils to damaged
tissue. Resolution of inflammation is thought to involve
neutrophil apoptosis. However, in zebra fish it has been
shown that less than 3% of the neutrophils undergo apop-
tosis at the wound site [5]. An alternative mechanism to
eliminate neutrophils from the wound site appears to be at
play, reverse migration of neutrophils from damaged tissue
back toward the vasculature [6].
Neutrophils are also recruited to damage sites by the
proinflammatory cytokine Interleukin-17A (IL-17A).
Interestingly, IL17A is also produced by neutrophils [7].
IL-17A-knockout mice show enhanced skin wound healing
and decreased neutrophil accumulation compared to wild-
type mice [8]. In line with this, administration of recom-
binant IL-17A led to delayed healing and enhanced neu-
trophilic accumulation. Furthermore, the treatment of IL-
17A-administered mice with a neutrophil elastase inhibitor
reestablished repair to the same level as that of WT mice.
These results indicate that IL-17A impairs wound healing
and suggest that neutrophilic inflammation caused by IL-
17A may be associated with impaired wound healing in
skin.
Macrophages represent the major population of resident
phagocytes in tissues under basal conditions. During
health, tissue-resident macrophages can be found in dif-
ferent organs and have vital roles in tissue development
and maintenance of homeostasis. Upon tissue damage and
inflammation, macrophages can arise from circulating
monocytes that infiltrate the wound site. Local tissue
damage leads to the swift recruitment of blood-derived, and
neighboring-tissue derived, monocytes that develop into
macrophages. These Infiltrating monocytes/macrophages
are the first cells that after the neutrophils penetrate the
damaged tissue. These infiltrating cells contribute to the
total pool of macrophages found at the wound site after
injury, together with the original tissue-resident pool.
Macrophages sense tissue damage and remove debris and
apoptotic cells from the wound site but also contribute to
initiation and progression of tissue repair. In several animal
models, amongst others in mice, guinea pig and zebra fish
models, it has been shown that depletion of macrophages
impairs regeneration [9–11].
Monocytes represent a highly plastic and dynamic cell
type that contributes to the local pool of macrophages.
Whether monocyte-derived macrophages and tissue-
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resident macrophages have similar functions under
inflammatory conditions is not elucidated yet.
Macrophages undergo phenotypic changes in response
to injury and repair. Macrophages are historically classified
according to their in vitro mode of activation as classically
activated macrophages (M1) or alternatively activated
(M2) macrophages [12]. M1 macrophages show pro-in-
flammatory properties by producing pro-inflammatory
cytokines such as tumor necrosis factor alpha (TNF-alpha)
and interleukin 1b (IL-1b). M2 macrophages, in contrast,
display anti-inflammatory and repair features by expressing
interleukin 10 (IL-10) and transforming growth factor b
(TGF-b). Recently, the concept has been developed that
this classification is too simplistic and it has undergone
substantial revision. A, new complex classification model
has been proposed based on activating stimuli, ontogeny,
activation markers and experimental setting owing to the
far more complex and distinct phenotypes of macrophages
in various tissues [13].
Also, other cells than neutrophils and monocytes
migrate to the damage site as have been found in murine
models of sterile inflammation. Dendritic cells and lym-
phocytes play their part in sterile inflammation and repair.
Dendritic cells are activated as a response to cell death and
promote T-lymphocyte responses to antigens presented by
these cells [14]. It has been shown that under sterile
inflammatory conditions memory T cells (CD8) are gen-
erated [15]. Not only T cells but also B cells are involved in
sterile inflammation. In the spleen a B cell response is
initiated through sterile inflammation [16]. Furthermore, it
has been shown that after myocardial infarction T and B
cells infiltrate the wound area [17]. Murine peritonitis
induced by injection of dead yeast particles results in
migration of innate lymphoid cells at the site of inflam-
mation [18]. What is more, invariant natural killer T cells
populated sterile hepatic wound in the late stage after
damage releasing the anti-inflammatory cytokine inter-
leukin-4 (IL-4) that was shown to improve wound healing
[19]. Interleukin-4 producing macrophages activating
invariant natural killer T cells to produce cytokines
including IL-4, IL-13, and interferon-gamma have been
detected in this system [20]. The production of IL-4 and
IL-13 appears to be important to resolve inflammation
since deficiency of IL-4, the IL-4 receptor or natural killer
cells increased peritonitis severity. These results indicate
that efferocytosis-induced IL-4 production and activation
of IL-4-producing invariant natural killer T cells by mac-
rophages appear to be required to resolve sterile inflam-
mation and promote tissue repair.
Starting with the infiltration of neutrophils and ending
with invariant natural killer T cells it is clear that repair and
inflammation cannot be considered as separate entities but
that these are all aspects of a continues process. The cells
and cytokines involved have not a single biological role but
have differential roles depending on the context and the
stage of damage and repair. A downside of this realization
is that a simple solution to boost repair by just inhibiting
inflammation is not a likely option.
3 Fracture repair and inflammation
Depending on the type of cartilage lesions, chondral or full
thickness defects, the repair reaction is completely differ-
ent from soft tissue repair or has a number of overlapping
attributes. This raises the question what we can learn from
soft tissue repair that helps us in improving cartilage repair.
A lesion that is more closely related to cartilage repair than
soft tissue repair is fracture healing. How inflammation
affects fracture repair can give us clues about the rela-
tionship between inflammation and cartilage repair.
Immediately after a bone is fractured a haematoma is
formed. This haematoma consists of cells from the bone
marrow, periosteum and the blood. The fracture triggers an
inflammatory reaction which is essential to start the healing
to progress. The inflammatory reaction causes the haema-
toma to coagulate between the fracture ends forming a
template for callus formation. The action of proinflamma-
tory molecules is critical to initiate the response of bone. It
has been shown that absence of TNF-alpha signaling in
TNF-receptor knockout mice leads to a delay in both
intramembranous and endochondral bone formation [21].
This observation indicates that inflammatory TNF-a sig-
naling makes the repair process possible, maybe by stim-
ulating mesenchymal stem cell recruitment and
differentiation [21].
In humans it is known that the sterile inflammation after
certain surgical procedures, such as hip replacement,
induces ectopic bone formation which can be prevented by
treatment of patients with NSAIDs [22]. In line with this
observation is the finding that in mice COX-2 is important
in bone healing [23]. COX-2 null mice have been shown to
have a highly reduced capacity for bone repair. Further-
more, in transplantation studies in mice using cortical bone
grafts it was shown that COX-2, produced by infiltrating
inflammatory cells and periosteal progenitors, is essential
in the early process of bone repair [24].
Fra-1 is a component of the transcription factor activator
protein-1 (AP-1) and a factor known to be involved in the
regulation of inflammation [25]. In Fra1 transgenic mice
chondrogenesis around the fracture site was impaired,
resulting in accumulation of fibrous tissue, which interfered
with efficient bone healing [26]. Unexpectedly, immedi-
ately after fracture, induction of the inflammatory media-
tors TNF-alpha, Interleukin (IL)-6, and COX-2 was
significantly suppressed in Fra-1 transgenic mice indicating
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reduced inflammation leads to impaired bone healing.
Administration of prostaglandinE2 (PGE2) to the fracture
site using a slow-release carrier significantly reduced
accumulation of fibrous tissue in Fra-1 transgenic mice and
chondrogenesis was partially restored. These data suggest
that the Fra-1-containing transcription factor AP-1 inhibits
fracture healing through suppression of inflammation-in-
duced chondrogenesis.
The above described findings indicate that early and
local inflammation stimulates bone healing. This appears to
be totally different for systemic inflammation. For instance,
systemic inflammation induced by systemic lipopolysac-
charide (LPS) administration in a mouse model for femoral
fracture repair impaired bone healing [27]. This effect was
associated with decreased revascularization and bone
turnover, and by increased abundance of macrophages.
Systemic treatment of mice with a soluble glycoprotein 130
fusion protein (blocking IL-6 trans signaling) or an anti-
IL6 antibody (blocking global IL-6 signaling) showed that
selective inhibition of IL-6 trans-signaling improved the
fracture healing while global IL-6 inhibition did not affect
fracture healing. These data suggest that classic signaling
might have beneficial effects on bone repair after injury
[28]. Administration of the NSAID diclofenac in the
inflammatory phase of bone repair in mice with or without
lipopolysaccharide-induced systemic inflammation showed
that administration of NSAIDs in the early stage of fracture
repair inhibits bone healing, with reduced osteoblast,
osteoclast, and macrophage activity, and even exacerbated
the negative effects of systemic inflammation on the
healing process [29]. It seems clear that systemic inflam-
mation, in contrast to local inflammation, impairs bone
healing but the underlying mechanisms remain poorly
defined.
4 Inflammation and cartilage repair
Cartilage damage can have different features. Chondral
cartilage defects are confined to the superficial cartilage
without damaging the subchondral bone at the moment of
trauma. Since cartilage is not innervated and avascular, a
chondral defect does not lead to a genuine repair response
as can be seen after soft tissue injury. These chondral
defects result in distorted joint mechanics, altered distri-
bution of cartilage loading and stresses, and degenerative
changes in the long run. In many trauma patients chondral
defects are not the sole lesion in the joint, cruciate ligament
rupture or meniscal tears can go alongside. As a result of
tissue damage inflammatory pathways will be activated in
the traumatized joint that will contribute to or interfere
with joint homeostasis and repair.
A full thickness defects is characterized by a cartilage
lesion in combination with a lesion into the subchondral
bone. Since this leads to the formation of a blood cloud,
repair is initiated, and the defect will be ultimately filled
with biomechanically inferior fibrocartilage. Normal hya-
line, articular cartilage is not formed, but in many cases the
fibrocartilage can prevent disability in the short run but
frequently lead to disability later.
The most widespread damaged cartilage can be found in
the joint of patients with osteoarthritis (or other types of
arthritis). Osteoarthritis is more generalized cartilage
damage compared to the focal defects in chondral and full
thickness lesions although also osteoarthritis can be focal
in the early stage. Furthermore, osteoarthritis is considered
a disease of the whole joint since changes are not confined
to the articular cartilage but also other joint tissues, e.g.
subchondral bone and synovium, are affected. Since car-
tilage damage in an OA joint can be widespread repairing
cartilage damage in an OA joint is even a greater challenge
than cartilage repair in a focal defect.
Articular cartilage has a very limited intrinsic repair
capacity leading to progressive joint damage when injured.
Mesenchymal stromal cells (MSC) are a promising tool for
tissue engineering of articular cartilage. The in vitro system
of chondrogenic differentiation of mesenchymal stem cells
in a three-dimensional culture system combined with the
addition of differentiation factors has widely been used as
model for chondrogenesis and cartilage formation. In
general, this system does not lead to the formation of
stable articular cartilage-like tissue. The most efficient
factors to induce chondrogenesis in this system include
members of the transforming growth factor beta super-
family in combination with dexamethasone [30]. Combi-
nations of these factors induce the expression of
chondrocyte specific genes in MSC, but these factors are
also highly anti-inflammatory. Both TGF-beta and corti-
costeroids belong to the most potent anti-inflammatory
molecules known [31–33]. Using these molecules in a
culture system of chondrogenesis it is not unexpected that
the effect of inflammatory factors will be underestimated in
this culture model. The effect of additional inflammatory or
anti-inflammatory factors being easily overruled by dex-
amethasone. We have observed that the effect of anti-in-
flammatory compounds on blocking the inhibitory effect of
inflammatory cytokines or inflamed conditioned medium
can be undetectable in the presence of dexamethasone, but
clearly present without (data not shown). One has to be
aware therefore that both the effect of inflammatory or anti-
inflammatory compounds can be underestimated in the
currently most used chondrogenic culture systems.
The repair of cartilage defects being either chondral,
full-thickness or as a results of (osteo)arthritis has to be
achieved in a milieu with tissue damage and as a
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consequence of this with minor or severe inflammation
[34, 35]. The amount of inflammation will differ consid-
erably between patients, but at least slight inflammation
will be present in all patients. Cartilage damage will release
DAMPS that will activate synovial lining cells via TLRs or
other DAMP receptors [36]. After an acute joint trauma
cytokine levels increase, and these will be elevated if
damage is not fully repaired [37, 38]. In the case of carti-
lage damage, it is known that spontaneous full repair in
human adults is rare or even considered to be absent. To
repair cartilage, strategies have been developed using
either chondrocytes or progenitor cells but the presence
variable inflammation in the damaged joint have to be
taken into account to make long term repair successful.
Children with chronic inflammatory disease exhibit
disturbed growth [39, 40]. Longitudinal growth depends on
normal growth plate functioning with strictly regulated
chondrocyte proliferation and differentiation, processes
that are also crucial in successful cartilage repair. Proin-
flammatory cytokines affect normal growth plate function
amongst others by affecting Insulin-like growth factor I
(IGF-I) signaling. Children with chronic inflammation have
elevated levels of IL-6 and TNF-alpha in their blood. These
children regularly show reduced systemic levels of IGF-I.
Furthermore, mice that over express TNF-alpha show
growth retardation. Inflammatory cytokines, such as TNF-
alpha and IL-1, inhibit differentiation of growth plates
chondrocytes and longitudinal growth [41]. Proinflamma-
tory cytokines IL-1, IL-6 and TNF-alpha inhibited chon-
drogenesis in an in vitro growth plate model using the
mesenchymal chondrogenic cell line RCJ3.1C5.18 [42].
These cytokines inhibited IGF-I-enhanced chondrocyte
differentiation by blocking IGF-I-specific signaling
pathways.
In particular the duration of exposure to proinflamma-
tory cytokines appears to be important. A short exposure
has little effects while long exposure leads to a severe and
irreversible reduction in growth [43]. These studies indi-
cate that proinflammatory cytokines interfere with normal
chondrocyte differentiation. Although differentiation of
growth plate chondrocytes and cartilage repair is different
there is an overlap in biological processes and one could
assume that the negative effect of proinflammatory factors
on growth plate chondrocytes has its equivalent in repair of
articular cartilage using progenitor cells.
In damaged joint inflammatory factors are produced
locally by cells in the synovial fluid or released in the
synovial fluid from surrounding tissues. Rodrigo et al. [44]
studied the effect of synovial fluid from knees with a
traumatic defect on chick limb chondrogenesis. Synovial
fluid from most of these patients stimulated chondrogenesis
(65%), the remainder had an no inhibitory effect (24%) or
was without effect (11%). Synovial fluid from chronically
injured knees was always inhibitory. In a study of Yang
using redifferentiaton of human chondrocytes as a model,
synovial fluid from injured knee joints inhibited cartilage-
related matrix synthesis [45]. Chondrogenesis of sub-
chondral mesenchymal cortico-spongious progenitor cells
was inhibited by synovial fluid from rheumatoid arthritis
patients but not by synovial fluid from osteoarthritis
patients or controls [46]. Apparently, synovial fluid con-
tains chondrogenesis promoting factors, but the positive
action of these factors can be overruled by inflammatory
factors present.
The source of these factors is currently not fully eluci-
dated. This can be the inflamed, activated synovium but
also other joint tissues can contribute. The infrapatellar fat
pad (IPFP) has been described as a source for inflammatory
factors [47]. Conditioned medium from the intrapatellar fat
pad from injured knee joints inhibits cartilage formation in
human MSC [48]. No differences were observed between
traumatically-injured or osteoarthritic joints. Furthermore,
conditioned medium from macrophages derived from the
infrapatellar fat pad also decreased chondrogenesis. Con-
ditioned medium obtained from cultures of M1 macro-
phages decreased chondrogenesis of human MSC while
this was not the case by medium from M2 macrophages
[49]. These results indicate that M1 macrophages are the
cells in the joint that release factors that inhibit
chondrogenesis.
In the presence of IL-1, the chondrogenic differentiation
and cartilage formation of bone marrow-derived MSC is
inhibited which can be partly overcome by culturing under
hypoxic conditions [50, 51]. In a study by Wehling et al.
[52], it was shown that both IL-1 and TNF-alpha inhibited
chondrogenesis in MSC in a dose dependent way which
correlated with activation of NF-kappaB. Specific inhibi-
tion of NF-kappaB blocked the activation of NF-kappaB
and rescued chondrogenesis. Similar findings were repor-
ted by Han et al. IL-1beta and TNF-alpha inhibited the
expression of chondrogenic-related genes in osteoarthritic
synovium-derived stem cells, which was counteracted by
knockdown of NF-kappaB and C/EBPbeta [53]. In our
studies we showed that IL-1 alpha was more potent than
TNF-alpha in inhibiting chondrogenesis of bone marrow-
derived human MSC. In addition, incubation of MSC with
conditioned medium of osteoarthritic synovium strongly
inhibited cartilage formation and this could be partially
overcome by blocking IL-1 but not by blocking TNF-alpha
[51]. Furthermore, the negative effects of OA synovium
conditioned medium could to a certain extent be overcome
by blocking JAK signaling using tofacitinib or TAK-1
signaling using oxozeaenol [54]. MSCs cannot only be
derived from bone marrow but also from synovial fluid.
Interferon-gamma and TNF-alpha decreased cartilage
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formation in equine MSC from either bone marrow or
synovial fluid [55].
In addition, also in human adipose derived mesenchy-
mal stem cells chondrogenesis is inhibited by IL-1 [56].
Addition of diallyl disulfide blocked the reduction of
chondrocyte marker gene expression by IL-1 in this sys-
tem. Furthermore, expression of anti-oxidant enzymes was
enhanced while ROS production and NF-KappaB signaling
was reduced. Also, melatonin has been shown to reduce
ROS accumulation and to inhibit the negative effects of IL-
1 and TNF alpha on chondrogenesis in MSC [57]. Overall
it clear that chondrogenesis of progenitor cells of various
sources is inhibited by inflammatory factors pointing
towards a negative effect of inflammation on chondroge-
nesis and new cartilage formation.
Inhibition of chondrogenesis is not only studied using
human progenitor cells but also cell lines have been used
and MSC from other species. Incubation of ATDC5 cells, a
clonal murine chondrogenic cell line, in a chondrogenic
culture system with IL-1 results in inhibition of chondro-
genesis [58]. Moreover, the protein 14-3-3g is induced by
TNF-alpha and found in the serum and synovial fluid of
patients with joint inflammation [59]. Chondrogenesis of
ATDC5 cells was inhibited by TNF but also by overex-
pression of 14-3-3g, while silencing of 14-3-3g stimulated
chondrogenesis [59]. As similar a effect was observed by
IL-6, a factor highly elevated under inflammatory condi-
tions. The expression of chondrogenic differentiation
marker genes was reduced by IL-6 in ATDC5 cells and this
was blocked by an anti-IL6 receptor antibody [60]. In a
study using murine bone marrow-derived MSC a similar
effect of IL-6 was observed [61]. Also, these studies
indicate that inflammatory factors block chondrogenesis
and will be inhibitory in the context of cartilage repair.
5 Concluding remarks
The relationship between inflammation and tissue repair is
not simple and uncomplicated. Soft tissue repair is quite
different from cartilage repair and therefore the role of
inflammation in soft tissue repair is hard to extrapolate to
cartilage repair. Surprisingly, also in fracture repair, which
is thought to have a number of characteristics similar to
cartilage repair, the role of inflammation seems to differ
from cartilage repair. In fracture healing it appears that
local inflammation is necessary for efficient repair and
blocking inflammation in the initial stage of repair is
deleterious. In contrast, in most (in vitro) models of
chondrogenesis and cartilage formation by progenitor cells
blocking inflammation enhances chondrogenesis and car-
tilage formation. Furthermore, systemic inflammation
appears to have a negative effect on all varieties of tissue
repair.
The discrepancy between fracture repair and cartilage
repair is unexpected since chondrogenesis is an important
aspect of both processes. The difference can be due to
several reasons. Studies investigating the role of inflam-
mation in fracture repair are mostly in vivo studies
involving a whole organism while studies investigating the
role of inflammation in cartilage are mostly in vitro studies.
It will be clear that the in vivo test system is more complex
involving feature that are missing in most in vitro studies,
such as loading and a complex interaction between dif-
ferent cell types. Furthermore, as pointed out earlier, the
currently used models of chondrogenesis, high growth
factor concentrations and high concentrations of corticos-
teroids, are quite nonphysiologic compared to the condi-
tions in a joint with a cartilage lesion. To really be able to
draw valid conclusions about the role of inflammation and
inflammatory factors on cartilage repair a in vitro model
system should be developed that more closely resembles
the actual conditions in a damaged joint.
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